You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 8, August 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (165)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cognitive Disorders
 •Schizophrenia
 •Alert me on articles by topic

Generalized Cognitive Deficits in Schizophrenia

A Study of First-Episode Patients

Somaia Mohamed, MD, PhD; Jane S. Paulsen, PhD; Daniel O'Leary, PhD; Stephen Arndt, PhD; Nancy Andreasen, MD, PhD

Arch Gen Psychiatry. 1999;56:749-754.

Background  Cognitive impairment is recognized as a core characteristic of schizophrenia. There has always been a debate about the nature, selectivity, and time of onset of these deficits in relationship to the onset of illness and treatment factors. To our knowledge, the present study represents the largest sample of mostly neuroleptic-naive patients with first-episode schizophrenia that has been reported to date.

Methods  A group of 94 patients experiencing their first episode of schizophrenic illness and 305 normal comparison subjects were administered a comprehensive clinical and neuropsychological evaluation. Seventy-three patients were neuroleptic naive, 14 had received treatment for less than 1 week, and the remaining 7 had been medicated for less than 2 weeks.

Results  Patients performed significantly worse than the comparison subjects on every neuropsychological variable except those assessing savings scores (ie, forgetting over time). Twenty-five of 30 tests had an effect size (ES) greater than 0.75 when the 2 groups were compared. An ES analysis within the schizophrenia group revealed that the greatest relative impairments were on the Wechsler Adult Intelligence Scale–Revised digit symbol (ES, -0.52) and comprehension (ES, -0.42) subscales.

Conclusions  Our findings are in concert with others demonstrating that significant cognitive impairment across multiple ability domains is a core characteristic of schizophrenia and is not caused by chronic illness, treatment, or institutionalization. The ES analysis emphasizes that patients with schizophrenia have a generalized deficit that is not easily explained by a single anatomical region or ability area.


From the Department of Psychiatry, Mental Health Clinical Research Center (Drs Mohamed, Paulsen, O'Leary, Arndt, and Andreasen), and the Department of Preventive Medicine and Environmental Health (Dr Arndt), University of Iowa, Iowa City.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive markers of short-term clinical outcome in first-episode psychosis
Bodnar et al.
Br. J. Psychiatry 2008;193:297-304.
ABSTRACT | FULL TEXT  

Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem
Dickinson and Harvey
Schizophr Bull 2008;0:sbn097v1-sbn097.
ABSTRACT | FULL TEXT  

The Relationship Between IQ, Memory, Executive Function, and Processing Speed in Recent-Onset Psychosis: 1-Year Stability and Clinical Outcome
Leeson et al.
Schizophr Bull 2008;0:sbn100v1-sbn100.
ABSTRACT | FULL TEXT  

Cognition in Young Schizophrenia Outpatients: Comparison of First-Episode With Multiepisode Patients
Braw et al.
Schizophr Bull 2008;34:544-554.
ABSTRACT | FULL TEXT  

Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Goldberg et al.
Arch Gen Psychiatry 2007;64:1115-1122.
ABSTRACT | FULL TEXT  

Cognition as an outcome measure in schizophrenia
Kraus and Keefe
Br. J. Psychiatry 2007;191:s46-s51.
ABSTRACT | FULL TEXT  

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Keefe et al.
Am. J. Psychiatry 2007;164:1061-1071.
ABSTRACT | FULL TEXT  

Psychomotor Slowing in Schizophrenia
Morrens et al.
Schizophr Bull 2007;33:1038-1053.
ABSTRACT | FULL TEXT  

Overlooking the Obvious: A Meta-analytic Comparison of Digit Symbol Coding Tasks and Other Cognitive Measures in Schizophrenia
Dickinson et al.
Arch Gen Psychiatry 2007;64:532-542.
ABSTRACT | FULL TEXT  

Cognitive Functioning in the Schizophrenia Prodrome
Simon et al.
Schizophr Bull 2007;33:761-771.
ABSTRACT | FULL TEXT  

Measuring Changes in Functional Status Among Patients With Schizophrenia: The Link With Cognitive Impairment
Matza et al.
Schizophr Bull 2006;32:666-678.
ABSTRACT | FULL TEXT  

Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy Volunteers.
Ho et al.
Arch Gen Psychiatry 2006;63:731-740.
ABSTRACT | FULL TEXT  

Cognitive Function and Symptoms in Adolescents with Schizotypal Personality Disorder
Trotman et al.
Schizophr Bull 2006;32:489-497.
ABSTRACT | FULL TEXT  

Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?
Harvey et al.
Schizophr Bull 2006;32:250-258.
ABSTRACT | FULL TEXT  

Relative Sparing of Executive Functions in the Early Phase of Schizophrenia
Atbasoglu et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:510-516.
ABSTRACT | FULL TEXT  

Developing Drugs for Cognitive Impairment in Schizophrenia
Breier
Schizophr Bull 2005;31:816-822.
ABSTRACT | FULL TEXT  

Neurobiology of early psychosis
KESHAVAN et al.
Br. J. Psychiatry 2005;187:s8-s18.
ABSTRACT | FULL TEXT  

Integrating non-drug treatments in early schizophrenia
LEWIS et al.
Br. J. Psychiatry 2005;187:s65-s71.
ABSTRACT | FULL TEXT  

A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
Buchanan et al.
Schizophr Bull 2005;31:5-19.
ABSTRACT | FULL TEXT  

First-episode schizophrenia: review of cognitive deficits and cognitive remediation
Gopal and Variend
Adv. Psychiatr. Treat. 2005;11:38-44.
ABSTRACT | FULL TEXT  

Cognitive Enhancement Therapy for Schizophrenia: Effects of a 2-Year Randomized Trial on Cognition and Behavior
Hogarty et al.
Arch Gen Psychiatry 2004;61:866-876.
ABSTRACT | FULL TEXT  

Neurocognitive Dysfunction in First-Episode Psychosis: Correlates With Symptoms, Premorbid Adjustment, and Duration of Untreated Psychosis
Rund et al.
Am. J. Psychiatry 2004;161:466-472.
ABSTRACT | FULL TEXT  

Lateralization of Auditory Sensory Gating and Neuropsychological Dysfunction in Schizophrenia
Thoma et al.
Am. J. Psychiatry 2003;160:1595-1605.
ABSTRACT | FULL TEXT  

Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia
Dickerson et al.
Arch Gen Psychiatry 2003;60:466-472.
ABSTRACT | FULL TEXT  

Mild Procedural Learning Disturbances in Neuroleptic-Naive Patients With Schizophrenia
Scherer et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:58-63.
ABSTRACT | FULL TEXT  

Relationship Between Premorbid Functioning and Symptom Severity as Assessed at First Episode of Psychosis
Rabinowitz et al.
Am. J. Psychiatry 2002;159:2021-2026.
ABSTRACT | FULL TEXT  

Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic
HAMBRECHT et al.
Br. J. Psychiatry 2002;181 :s30-s37.
ABSTRACT | FULL TEXT  

Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study
JOYCE et al.
Br. J. Psychiatry 2002;181 :s38-s44.
ABSTRACT | FULL TEXT  

Longitudinal Assessment of Premorbid Cognitive Functioning in Patients With Schizophrenia Through Examination of Standardized Scholastic Test Performance
Fuller et al.
Am. J. Psychiatry 2002;159:1183-1189.
ABSTRACT | FULL TEXT  

Impaired Sensory Processing as a Basis for Object-Recognition Deficits in Schizophrenia
Doniger et al.
Am. J. Psychiatry 2001;158:1818-1826.
ABSTRACT | FULL TEXT  

Enhancement of Cognitive Performance in Schizophrenia by Addition of Tandospirone to Neuroleptic Treatment
Sumiyoshi et al.
Am. J. Psychiatry 2001;158:1722-1725.
ABSTRACT | FULL TEXT  

Parental Origin of the Deletion 22q11.2 and Brain Development in Velocardiofacial Syndrome: A Preliminary Study
Eliez et al.
Arch Gen Psychiatry 2001;58:64-68.
ABSTRACT | FULL TEXT  

Neuropsychological Differences Between First-Admission Schizophrenia and Psychotic Affective Disorders
Mojtabai et al.
Am. J. Psychiatry 2000;157:1453-1460.
ABSTRACT | FULL TEXT  

Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
McGlashan and Hoffman
Arch Gen Psychiatry 2000;57:637-648.
ABSTRACT | FULL TEXT  

Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
Bilder et al.
Am. J. Psychiatry 2000;157:549-559.
ABSTRACT | FULL TEXT  

Cognitive Correlates of the Negative, Disorganized, and Psychotic Symptom Dimensions of Schizophrenia
O'Leary et al.
J. Neuropsychiatry Clin. Neurosi. 2000;12:4-15.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.